Spearhead Capital Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
2022
Q2
$314K Sell
2022
Q1
$355K Sell
2021
Q4
$523K Buy
2021
Q3
$551K Buy
2021
Q2
$480K Buy
2021
Q1
$343K Buy
2020
Q4
$275K Buy
2020
Q3
$295K Buy
2020
Q2
$282K Buy